Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 425-200-9 | CAS number: -
A GPMT according to OECD406 was performed to assess the skin sensitisation potential of Montaverdi. Dose levels selected for this study were
intradermal injection 7.5% v/v in Alembicol D, topical application as supplied and challenge application as supplied and 50% v/v in Alembicol D. Ten test and five control guinea-pigs were used in this study. Montaverdi did not produce evidence of skin sensitisation (delayed contact hypersensitivity) in any of the ten test animals and therefore does not require labelling with the risk phrase R43 "May cause sensitisation by skin contact" in accordance with the DSD 67/548/EEC or the CLP Regulation (EC) No. 1272/2008.
In the GPMT study Montaverdi did not produce evidence of skin sensitisation (delayed contact hypersensitivity) in any of the ten test animals and therefore does not require labelling in accordance with the DSD 67/548/EEC or the CLP Regulation (EC) 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
Close Do not show this message again